In vitro fertilization (IVF) has advanced significantly with the development of genetic testing technologies that can help doctors evaluate embryos before transfer. Two commonly discussed technologies are PGD and PGS. Understanding PGD vs. PGS in IVF can help intended parents learn how embryo testing may fit into their fertility treatment plan.

What Is PGD in IVF?

PGD, or Preimplantation Genetic Diagnosis, is a genetic testing approach traditionally used to identify specific inherited genetic disorders in embryos created through IVF. It may be considered when one or both prospective parents are known carriers of a particular genetic condition.

PGD can help identify embryos that are less likely to carry the specific genetic condition being tested for. This may allow the fertility specialist to select suitable embryos for transfer.

Today, the terminology has evolved, and many clinics use the broader term PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) for testing embryos for specific single-gene disorders.

What Is PGS in IVF?

PGS stands for Preimplantation Genetic Screening. It was the earlier term commonly used for screening embryos for chromosome number abnormalities. The modern term is generally PGT-A (Preimplantation Genetic Testing for Aneuploidy).

PGT-A evaluates whether an embryo has the expected number of chromosomes. Chromosomal abnormalities may sometimes be associated with implantation failure, miscarriage, or certain genetic conditions.

PGT-A does not test for every genetic or inherited disorder. Instead, it primarily focuses on chromosome number.

PGD vs. PGS in IVF: Main Difference

The key difference between PGD and PGS is what they are designed to evaluate.

PGD focuses on a specific known genetic disorder, while PGS, now generally referred to as PGT-A, focuses on chromosome abnormalities.

For example, if prospective parents have a known risk of passing on a particular single-gene disorder, a specialist may discuss PGT-M. If the concern is embryo chromosome number, PGT-A may be considered.

Because genetic testing is highly specialized, the appropriate option depends on individual medical history, age, reproductive history, and the recommendations of a fertility specialist.

Why Is Embryo Genetic Testing Considered?

Embryo genetic testing may be considered in selected IVF cases to provide additional information about embryos before transfer. Depending on the type of testing, it can help identify embryos affected by a specific genetic condition or embryos with chromosome-number abnormalities.

However, genetic testing does not guarantee pregnancy or a healthy baby. IVF outcomes depend on multiple factors, including embryo quality, uterine health, maternal age, sperm factors, and other medical considerations.

For guidance about IVF and embryo genetic testing,

📞 Contact Us: +91–8447592299
📧 Email us: info@selectivf.com

Select IVF can help intended parents understand available fertility treatment options and discuss whether genetic testing may be appropriate for their individual situation.

Press enter or click to view image in full size

PGD vs. PGS in IVF: Which One Is Better?

There is no universal answer because PGD/PGT-M and PGS/PGT-A are designed for different purposes. The appropriate test depends on the reason for testing.

PGT-M may be particularly relevant when there is a known risk of a specific inherited single-gene disorder. PGT-A may be discussed when chromosome-number screening is considered appropriate as part of IVF treatment.

Patients should not choose genetic testing solely because it is available. A fertility specialist and, when appropriate, a genetic counsellor can explain the potential benefits, limitations, costs, and implications of testing.

Important Things to Consider

Before undergoing embryo genetic testing, prospective parents should discuss several factors with their fertility team. These can include the reason for testing, the type of test recommended, the number of embryos available, possible testing limitations, embryo biopsy procedures, costs, and how the results may influence embryo selection.

It is also important to understand that genetic testing results can sometimes require careful interpretation. Therefore, professional counselling can be valuable when making treatment decisions.

Conclusion

Understanding PGD vs. PGS in IVF is important for anyone considering advanced embryo testing during IVF. While PGD is traditionally associated with identifying specific inherited genetic disorders, PGS is the older term associated with chromosome screening, now generally called PGT-A.

Neither approach is automatically suitable for every IVF patient. A personalized assessment can help determine whether genetic testing is appropriate and which type may provide useful information.

If you are exploring IVF, embryo testing, or other fertility treatment options, Select IVF can help you understand the available choices and connect them with your individual treatment needs.

📞 Contact Us: +91–8447592299
📧 Email us: info@selectivf.com